Total Debt
$16.3M
Net Debt
-$265.2M
Keros Therapeutics, Inc. currently has $16.3M in total debt. Net debt is -$265.2M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
KROS • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.02 | 0.28 | -0.27Net Cash | 0.31 | 5.2% |
| 2025-12-31 | 0.02 | 0.29 | -0.27Net Cash | 0.34 | 5.0% |
| 2025-09-30 | 0.02 | 0.69 | -0.68Net Cash | 0.74 | 2.3% |
| 2025-06-30 | 0.02 | 0.69 | -0.67Net Cash | 0.76 | 2.4% |
| 2025-03-31 | 0.02 | 0.72 | -0.70Net Cash | 0.78 | 2.3% |
| 2024-12-31 | 0.02 | 0.56 | -0.54Net Cash | 0.62 | 3.1% |
| 2024-09-30 | 0.02 | 0.53 | -0.51Net Cash | 0.58 | 3.3% |
| 2024-06-30 | 0.01 | 0.41 | -0.39Net Cash | 0.46 | 3.1% |
| 2024-03-31 | 0.01 | 0.44 | -0.43Net Cash | 0.49 | 2.9% |
| 2023-12-31 | 0.01 | 0.33 | -0.32Net Cash | 0.37 | 3.9% |
| 2023-09-30 | 0.01 | 0.29 | -0.27Net Cash | 0.33 | 4.4% |
| 2023-06-30 | 0.01 | 0.32 | -0.31Net Cash | 0.36 | 3.9% |
| 2023-03-31 | 0.01 | 0.35 | -0.34Net Cash | 0.38 | 3.6% |
| 2022-12-31 | 0.01 | 0.28 | -0.27Net Cash | 0.31 | 4.3% |
| 2022-09-30 | 0.00 | 0.24 | -0.24Net Cash | 0.25 | 0.2% |
| 2022-06-30 | 0.00 | 0.22 | -0.21Net Cash | 0.23 | 0.3% |
| 2022-03-31 | 0.00 | 0.23 | -0.23Net Cash | 0.24 | 0.4% |
| 2021-12-31 | 0.00 | 0.23 | -0.23Net Cash | 0.26 | 0.4% |
| 2021-09-30 | 0.00 | 0.22 | -0.22Net Cash | 0.23 | 0.6% |
| 2021-06-30 | 0.00 | 0.24 | -0.24Net Cash | 0.24 | 0.3% |
| 2021-03-31 | 0.00 | 0.26 | -0.25Net Cash | 0.26 | 0.3% |
| 2020-12-31 | 0.00 | 0.27 | -0.26Net Cash | 0.27 | 0.3% |
| 2020-09-30 | 0.00 | 0.13 | -0.13Net Cash | 0.14 | 0.7% |
| 2020-06-30 | 0.00 | 0.14 | -0.14Net Cash | 0.15 | 0.7% |
| 2020-03-31 | 0.08 | 0.05 | 0.02 | 0.06 | 126.9% |
| 2019-12-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 11.6% |
| 2019-03-31 | 0.00 | 0.02 | -0.02Net Cash | 0.00 | — |